To have your comment included in a future podcast, call 617-440-4374. Please leave your name, number, and the podcast ID number.
Podcast 136: Aspirin lowers colorectal risks in Lynch syndrome — what are the implications for everyone else?
Joe Elia • November 4th, 2011
Categories: aspirin, Audio, colorectal cancer, Lynch syndrome, Uncategorized
Last week’s Lancet article on the effect of aspirin on risks for colorectal cancer in patients with Lynch syndrome — a group at particularly high risk — may hold implications for preventing sporadic colon cancers.
Our interview with Prof. Sir John Burn, the study’s first author, explores those implications as well speculations on why we human beings aren’t getting the salicylates we were when our vegetables weren’t so pampered.
- Physician’s First Watch coverge (free)
- Lancet abstract (free)
- NEJM 2008 paper (free)
- The CAPP3 website